CDC investigating hospitalizations of five people who recently received chikungunya vaccine
The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people ...
DPA International on MSN1d
EU authorizes chikungunya virus vaccine for adults and adolescents
The European Commission on Friday authorized a vaccine against the chikungunya virus - a mosquito-borne disease - for adults ...
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and ...
Daily1d
Biological E collaborate with Bavarian Nordic to expand Chikungunya Vaccine access in low, middle income countries
Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...
Becker's Hospital Review3d
CDC probes hospitalizations after chikungunya vaccination
Five older adults hospitalized after receiving chikungunya vaccine, prompting CDC investigation. Few adverse reactions reported in clinical trials.
manilatimes1d
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...
Biological E teams with Danish vax firm to give Chikungunya jabs to LMICs
Hyderabad-based Biological E. Limited (BE) is partnering with Danish firm Bavarian Nordic to expand access to the latter’s ...
CNN3d
CDC investigating hospitalizations of five people who recently received chikungunya vaccine
CNN has reached out to the CDC for comment. Chikungunya virus is typically spread to people through the bite of an infected mosquito. Most adults don’t receive the vaccine; it is sometimes ...
Bavarian Nordic A/S: Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved in Europe for persons as young as 12 years old.On track for launch in key European markets in the first half of 2025. COPENHAGEN, Denmark, February 28, 2025 ...